Mechanism of programmed cell death factor 4/nuclear factor-κB signaling pathway in porcine coronary micro-embolization-induced cardiac dysfunction

Experimental Biology and Medicine

Volumn 240, Issue 11, 2015, Pages 1426-1433

  Su, Qiang ^a   Li, Lang ^a   Wang, Jiangyou ^a   Zhou, You ^a   Liu, Yangchun ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

cardiac function; Coronary micro embolization; nuclear factor B; programmed cell death factor 4; vascular intervention

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE RECEPTOR; PICRIC ACID; PROGRAMMED CELL DEATH FACTOR 4; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; BIOPSY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; HEART DILATATION; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROEMBOLISM; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYSTOLIC DYSFUNCTION; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CORONARY BLOOD VESSEL; CYTOLOGY; DISEASE MODEL; EMBOLISM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART OUTPUT; INFLAMMATION; METABOLISM; MINIPIG; PATHOLOGY; PIG;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BIOPSY; CARDIAC OUTPUT; CORONARY VESSELS; DISEASE MODELS, ANIMAL; EMBOLISM; FEMALE; INFLAMMATION; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; PICRATES; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SWINE; SWINE, MINIATURE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84944102029     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370215573400     Document Type: Article

References (18)

1. Y.HiguchiK.IwakuraA.OkamuraM.DateH.NagaiM.OzawaH.ItoK.Fujii. Effect of embolic particles during coronary interventional procedures on regional wall motion in patients with stable angina pectoris. Am J Cardiol2012; 109: 1142–7.
2. D.BoseC.von BirgelenX.Y.ZhouA.SchmermundS.PhilippS.SackT.KonorzaS.MöhlenkampK.LeineweberP.KleinbongardW.WijnsG.HeuschR.Erbel. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol2008; 103: 587–97.
3. I.MorishimaT.SoneK.OkumuraH.TsuboiJ.KondoH.MukawaH.MatsuiY.TokiT.ItoT.Hayakawa. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol2000; 36: 1202–9.
4. Y.LuL.LiX.ZhaoW.HuangW.Wen. Beta blocker metoprolol protects against contractile dysfunction in rats after coronary microembolization by regulating expression of myocardial inflammatory cytokines. Life Sci2011; 88: 1009–15.
5. S.LiS.ZhongK.ZengY.LuoF.ZhangX.SunL.Chen. Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res Cardiol2010; 105: 139–50.
6. A.HilliardB.HilliardS.J.ZhengH.SunT.MiwaW.SongR.GökeY.H.Chen. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol2006; 177: 8095–102.
7. F.J.SheedyE.Palsson-McDermottE.J.HennessyC.MartinJ.J.O'LearyQ.RuanD.S.JohnsonY.ChenL.A.O'Neill. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol2010; 11: 141–7.
8. Q.SuL.LiY.ZhouJ.WangY.LiuG.Ma. Induction of myocardial PDCD4 in coronary microembolization-related cardiac dysfunction: evidence from a large-animal study. Cell Physiol Biochem2014; 34: 533–42.
9. J.WangL.LiQ.SuY.ZhouH.ChenG.MaT.LiuZ.TangY.Liu. The involvement of phosphatase and tensin homolog deleted on chromosome ten (PTEN) in the regulation of inflammation following coronary microembolization. Cell Physiol Biochem2014; 33: 1963–74.
10. Q.SuL.LiY.C.LiuY.ZhouY.G.LuW.M.Wen. Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in rats. Exp Clin Cardiol2013; 18: 161–5.
11. L.LiQ.SuY.WangR.DaiY.LuB.SuY.Zhao. Effect of atorvastatin (Lipitor) on myocardial apoptosis and caspase-8 activation following coronary microembolization. Cell Biochem Biophys2011; 61: 399–406.
12. L.LiD.H.LiN.QuW.M.WenW.Q.Huang. The role of ERK1/2 signaling pathway in coronary microembolization-induced rat myocardial inflammation and injury. Cardiology2010; 117: 207–15.
13. G.HeuschP.KleinbongardD.BoseB.LevkauM.HaudeR.SchulzR.Erbel. Coronary microembolization: from bedside to bench and back to bedside. Circulation2009; 120: 1822–36.
14. N.M.MalyarL.O.LermanM.GosslP.E.BeighleyE.L.Ritman. Relation of nonperfused myocardial volume and surface area to left ventricular performance in coronary microembolization. Circulation2004; 110: 1946–52.
15. Q.SuL.LiY.LiuY.ZhouJ.WangY.Sun. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention. Cardiology2014; 127: 169–75.
16. S.DongY.ChengJ.YangJ.LiX.LiuX.WangD.WangT.J.KrallE.S.DelphinC.Zhang. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem2009; 284: 29514–25.
17. Y.ChengP.ZhuJ.YangX.LiuS.DongX.WangB.ChunJ.ZhuangC.Zhang. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res2010; 87: 431–9.
18. H.DorgeR.SchulzS.BelosjorowH.PostA.van de SandI.KonietzkaS.FredeT.HartungJ.Vinten-JohansenK.A.YoukerM.L.EntmanR.ErbelG.Heusch. Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol2002; 34: 51–62.